GW & Wade »

Vertex Pharmaceuticals Incorporated shares owned by GW & Wade

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by GW & Wade from 13F filings

Historical chart of GW & Wade investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by GW & Wade consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by GW & Wade

Quarter filed Position value Share count Share price at filing
2023-12-31 $410k 1.0k 407.15
2023-09-30 $263k 757 347.42
2023-06-30 $288k 818 352.08
2023-03-31 $201k 638 315.05
2022-12-31 $214k 740 289.19

More positions owned by GW & Wade

Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Wisdomtree Tr Us Largecap Divd (DLN)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Exxon Mobil Corporation (XOM)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Scp Etf (IJR)
Broadcom (AVGO)
Ishares Tr Rus 1000 Val Etf (IWD)
Procter & Gamble Company (PG)

View all positions for GW & Wade

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates
Amundi
Massachusetts Financial Services
Bank of America Corporation
Northern Trust
ClearBridge Advisors
Invesco
Bank of New York Mellon
T. Rowe Price Associates
Renaissance Technologies

View all funds holding Vertex Pharmaceuticals Incorporated